Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Cost of Revenue (2019 - 2025)

Silo Pharma's Cost of Revenue history spans 7 years, with the latest figure at $20687.0 for Q3 2025.

  • For Q3 2025, Cost of Revenue rose 1317.89% year-over-year to $20687.0; the TTM value through Sep 2025 reached $25066.0, up 329.36%, while the annual FY2024 figure was $5838.0, 0.0% changed from the prior year.
  • Cost of Revenue for Q3 2025 was $20687.0 at Silo Pharma, up from $1459.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $20687.0 in Q3 2025 and bottomed at $625.0 in Q1 2021.
  • The 5-year median for Cost of Revenue is $1460.0 (2021), against an average of $2427.6.
  • The largest annual shift saw Cost of Revenue plummeted 98.99% in 2021 before it soared 1317.89% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $1460.0 in 2021, then changed by 0.0% to $1460.0 in 2022, then changed by 0.0% to $1460.0 in 2023, then changed by 0.0% to $1460.0 in 2024, then skyrocketed by 1316.92% to $20687.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Cost of Revenue are $20687.0 (Q3 2025), $1459.0 (Q2 2025), and $1460.0 (Q1 2025).